Organic Chemists from Industry and academics to Interact on Spectroscopy Techniques for Organic Compounds ie NMR, MASS, IR, UV Etc. Starters, Learners, advanced, all alike, contains content which is basic or advanced, by Dr Anthony Melvin Crasto, Worlddrugtracker, email me ........... amcrasto@gmail.com, call +91 9323115463 India skype amcrasto64
................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Pages
- Home
- ABOUT ME
- DIMENSIONS IN NMR SPECTROSCOPY
- 13 C NMR
- 1H NMR
- CHEMDOODLE/INTERACTIVE SPECT PREDICT
- Animations
- HELP ME
- Multinuclear NMR Spectroscopy
- Examples of 13C NMR
- Books on NMR spectroscopy
- UV-Visible Spectroscopy
- IR SPECTRA EXAMPLES
- Journals
- Organic spectroscopy site
- Spectroscopy sites
- IR SPECTROSCOPY
- Books-2
- Recommended Web Sites for Spectra and Spectrum-rel...
- DISCLAIMER
- Mössbauer spectroscopy
- FINDING CHEMICAL SPECTRA
- Mass Spectrometry
- NMR Overview
- Characterisation of Organic Compounds
- SDBS Spectral Database System for Organic Compounds
- CHEMICAL SHIFT
- MASS SPECTROSCOPY
- Books-1
- MASSBANK PORTAL
- 11B NMR
Thursday, 18 December 2014
Drug delivery systems for cancer chemotherapy.
http://web.calstatela.edu/dept/chem/ba/researchtops-deriv.htm
Overlay of NOESY (blue) and TOCSY (red) 2D NMR spectra to assign the chemical shifts of self-complementary 5'-GAAGTACTTC-3' dsDNA in a 50% D2O, ...
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
Rotamers- assigned by a simple NMR experiment
READ AT
http://sussexdrugdiscovery.wordpress.com/2013/04/09/rotamers-assigned-by-a-simple-nmr-experiment/
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
Wednesday, 17 December 2014
Arterolane maleate
Arterolane
cas 664338-39-0, UNII-3N1TN351VB, OZ277, RBX-11160, NCGC00274173-01
Molecular Formula: C22H36N2O4
Molecular Weight: 392.53224
Ranbaxy Lab Ltd innovator
cis-adamantane-2-spiro-3’-8’-[[[(2’-amino-2’ methylpropyl) amino] carbonyl] methyl] 1’,2’,4’-trioxaspiro [4.5] decane
cis-adamantane-2-spiro-3′-8′-[[[(2′- amino-2′-methylpropyl)amino]carbonyl]-methyl]- 1 ‘,2′,4′-trioxaspiro[4.5]decane
Arterolane maleate is a synthetic trioxolane compound. The chemical name of arterolane maleate is cis-adamantane-2-spiro-3’-8’-[[[(2’-amino-2’ methylpropyl) amino] carbonyl] methyl] 1’,2’,4’-trioxaspiro [4.5] decane hydrogen maleate. The molecular formula is C26H40N2O8 and molecular weight is 508.61. The structural formula is as follows:
PATENT
Example 6: Preparation of c/s-adamantane-2-spiro-3′ -8 ‘-πT(2′-amino-2′ -methyl propyl) amino! carbonyl] methyli-l ‘, 2\ 4′-U-JoXaSpJrQ [4.51 decane maleate To a solution of c/s-adamantane-2-spiro-3′-8′-[[[(2′-amino-2′-methyl propyl) amino] carbonyl] methyl]-! ‘, 2′, 4′-trioxaspiro [4.5] decane (example 5) (60 g, 0.153 moles) in ethanol (150 mL) was added a solution of maleic acid (17.3 g, 0.15 moles, 0.98 equiv. in ethanol 90 mL) and the reaction mixture was stirred for about 1 h. To this clear solution, n- heptane (720 mL) was added at room temperature in 1 h and the reaction mixture was stirred for 3 h. It was then cooled to 0 to 100C and filtered. The cake was washed with n-heptane (60 mL) and dried under vacuum at 40-450C.
Yield: 67 g, 77.4%,
mp: 1490C (decomp),
(M++l) 393.5,
1HNMR (300 MHz, DMSO-^ ): δ 1.05-1.11 (2H,m), 1.18 (6H,s), 1.64-1.89 (21H,m), 2.07(2H,d), 3.21 (2H,d), 6.06 (2H,d), 7.797 (2H, bs), 8.07 (IH, t).
SEE FULL ARTICLE WITH SYNTHESIS AT
http://newdrugapprovals.org/2014/12/18/ranbaxy-to-introduce-malarial-treatment-synriam-in-african-nations/
NMR PREDICTIONS
amcrasto@gmail.com
amcrasto@gmail.com
NMR PREDICTIONS
H-NMR spectral analysis
CAS NO. 664338-39-0, Arterolane H-NMR spectral analysis |
C-NMR spectral analysis
CAS NO. 664338-39-0, Arterolane C-NMR spectral analysis |
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
NORWAY\
Norway: Oslo to Bergen by train
ALESUND
Stave church Heddal, Norway
Norway Bergen Tramway
At the top of Preikestolen with view over the Lysefjord, Norway
Norway - Bergen Cityscape by AgiVega
Tuesday, 16 December 2014
Xanifolia- Y and Y1
............
US20130190261
The invention provides a compound comprising the following structure, with the formula of C57H88O23 and the name of 3-O-β-D-galactopyranosyl(1→2)]-α-L-arabinofuranosyl(1→3)-β-D-glucuronopyranosyl-21,22-O-diangeloyl-3β,15α,16α, 21β,22α,28-hexahydroxyolean-12-ene, also known as Xanifolia-Y This compound was isolated from Xanthoceras sorbifolia.
This invention provides a compound comprising the following structure, with the formula of C65H100O27 and
the name of
3-O-[β-D-galactopyranosyl(1→2)]-α-L-arabinofuranosyl(1→3)-β-D-glucuronopyranosyl-21-O-(3,4-diangeloyl)-α-L-rhamnophyranosyl-22-O-acetyl-3β,16α,2β,22α,28-pentahydroxyolean-12-ene,
also known as Xanifolia-Y1
The above compounds (Y and Y1) have anti-cancer effect
The above compounds (Y and Y1) have anti-cancer effect
FIG. 11 shows the spectrum of proton NMR of Compound Y.
FIG. 12 shows 2D NMR (HMQC) results of Compound Y. Also see Table 5.2 for the listed chemical shift data.
FIG. 13 shows 2D NMR (HMBC) results of Compound Y. Also see Table 5.3 for the listed chemical shift data.
FIG. 15 shows the Mass spectrum of compound Y with ESI-MS.
FIG. 16 shows the Proton NMR spectrum of Compound Y1.
FIG. 17 shows the 2D NMR (HMQC) results of Compound Y1. Also see the chemical shift data from Table 6.2.
FIG. 18 shows the 2D NMR (HMBC) results of Y1. Also see the chemical shift data from Table 6.3.
FIG. 19 shows COSY-NMR profile of Y1 with chemical shift data from Table 6.4.
see
FIG. 12 shows 2D NMR (HMQC) results of Compound Y. Also see Table 5.2 for the listed chemical shift data.
FIG. 13 shows 2D NMR (HMBC) results of Compound Y. Also see Table 5.3 for the listed chemical shift data.
FIG. 15 shows the Mass spectrum of compound Y with ESI-MS.
FIG. 16 shows the Proton NMR spectrum of Compound Y1.
FIG. 17 shows the 2D NMR (HMQC) results of Compound Y1. Also see the chemical shift data from Table 6.2.
FIG. 18 shows the 2D NMR (HMBC) results of Y1. Also see the chemical shift data from Table 6.3.
FIG. 19 shows COSY-NMR profile of Y1 with chemical shift data from Table 6.4.
see
http://www.google.com/patents/US20130190261
amcrasto@gmail.com
amcrasto@gmail.com
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
amcrasto@gmail.com
http://newdrugapprovals.org/
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO
Subscribe to:
Posts (Atom)